Additionally, interactions and correlations between PROX1 and α-SMA expression were explored concerning disease progression and clinical outcomes, aiming to substantiate the role of PROX1 in CAFs, particularly in CRC-TME modulation. Here, PROX1 is linked to colorectal carcinoma.